Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
33,113
Total Claims
$2.8M
Drug Cost
1,004
Beneficiaries
$2,813
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+163%
Cost per patient vs peers
$2,813 vs $1,068 avg
+44%
Brand preference vs peers
12.9% vs 9.0% avg
Brand vs Generic
Brand: 4,246 claims · $2.3M
Generic: 28,627 claims · $501K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tirzepatide | 206 | $231K |
| Apixaban | 272 | $225K |
| Dulaglutide | 127 | $159K |
| Empagliflozin | 156 | $155K |
| Semaglutide | 125 | $145K |
| Dapagliflozin Propanediol | 162 | $141K |
| Linaclotide | 156 | $119K |
| Insulin Glargine,hum.Rec.Anlog | 152 | $117K |
| Fluticasone/Umeclidin/Vilanter | 121 | $85K |
| Rivaroxaban | 81 | $69K |
| Sitagliptin Phosphate | 65 | $66K |
| Modafinil | 12 | $58K |
| Budesonide/Formoterol Fumarate | 112 | $56K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $49K |
| Mirabegron | 37 | $36K |
Prescribing Profile
Patient Profile
71
Avg Age
50%
Female
1.34
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data